APIS Assay Technologies

APIS Assay Technologies possesses deep expertise and capabilities in the IVD development of molecular and immunoassays, with the final products realized as diagnostic tests. Additionally, APIS's expertise in bioinformatics and software development provides agile services to our clients, developing customized end-to-end multi-omics solutions and platform development. The new APIS Breast Cancer Subtyping Kit is a highly reproducible RT-qPCR-based IVD product (in certain regions) and RUO product used for detecting standard markers (HER2, ER, PR, Ki67) as well as novel proliferation biomarkers. The results of this test can help clinicians identify the right treatment more quickly and accurately.